ANI Pharmaceuticals Inc (ANIP)
65.43
-0.71
(-1.07%)
USD |
NASDAQ |
Apr 24, 16:00
65.41
-0.02
(-0.03%)
Pre-Market: 20:00
ANI Pharmaceuticals Total Assets (Quarterly): 904.42M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 904.42M |
| September 30, 2023 | 889.91M |
| June 30, 2023 | 859.34M |
| March 31, 2023 | 765.22M |
| December 31, 2022 | 760.09M |
| September 30, 2022 | 739.11M |
| June 30, 2022 | 751.33M |
| March 31, 2022 | 744.85M |
| December 31, 2021 | 771.60M |
| September 30, 2021 | 470.45M |
| June 30, 2021 | 480.16M |
| March 31, 2021 | 463.84M |
| December 31, 2020 | 461.19M |
| September 30, 2020 | 462.58M |
| June 30, 2020 | 465.39M |
| March 31, 2020 | 482.23M |
| December 31, 2019 | 456.79M |
| September 30, 2019 | 456.78M |
| June 30, 2019 | 446.91M |
| March 31, 2019 | 434.39M |
| December 31, 2018 | 430.60M |
| September 30, 2018 | 439.44M |
| June 30, 2018 | 424.18M |
| March 31, 2018 | 418.02M |
| December 31, 2017 | 412.14M |
| Date | Value |
|---|---|
| September 30, 2017 | 370.47M |
| June 30, 2017 | 359.22M |
| March 31, 2017 | 357.14M |
| December 31, 2016 | 322.86M |
| September 30, 2016 | 319.38M |
| June 30, 2016 | 308.00M |
| March 31, 2016 | 291.59M |
| December 31, 2015 | 285.26M |
| September 30, 2015 | 283.28M |
| June 30, 2015 | 270.12M |
| March 31, 2015 | 265.98M |
| December 31, 2014 | 259.56M |
| September 30, 2014 | 107.64M |
| June 30, 2014 | 95.42M |
| March 31, 2014 | 96.65M |
| December 31, 2013 | 44.50M |
| September 30, 2013 | 43.29M |
| June 30, 2013 | 41.66M |
| March 31, 2013 | 35.36M |
| December 31, 2012 | 38.77M |
| September 30, 2012 | 43.21M |
| June 30, 2012 | 47.29M |
| March 31, 2012 | 54.57M |
| December 31, 2011 | 62.38M |
| September 30, 2011 | 74.89M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
446.91M
Minimum
Jun 2019
904.42M
Maximum
Dec 2023
622.75M
Average
482.23M
Median
Mar 2020
Total Assets (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | 787.22M |
| ADMA Biologics Inc | 329.18M |
| Dentsply Sirona Inc | 7.37B |
| Allogene Therapeutics Inc | 642.84M |
| Vanda Pharmaceuticals Inc | 648.44M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 446.82M |
| Shareholders Equity (Quarterly) | 457.60M |
| Debt to Equity Ratio | 0.6243 |
| Current Ratio | 3.573 |
| Net Debt Paydown Yield | 0.02% |